Foresee Genomics (פורסי גנומיקס) is developing an innovative testing kit for identifying multiple cancer genomic markers simultaneously in a revolutionary process that combines molecular biology and computational analysis. Foresee Genomics offers dramatic reduction in diagnostic costs with comparison to present genomic tests, and replaces the need to hold costly genomic centers. The hands-on procedure is easy, fast, requires simple equipment, and designed for existing diagnostic labs in hospitals or clinical centers.